Incidence and Prognosis of Refractory Hypertension in Patients

Among patients with hypertension who initiate treatment, 1 in 50 patients develops refractory hypertension. Patients with refractory hypertension are at increased risk of cardiovascular events, supporting the need for increased efforts to improve hypertension outcome in this population.

  • resistant hypertension,
  • diabetes mellitus
  • Antihypertensive

Related Conference of Incidence and Prognosis of Refractory Hypertension in Patients

May 30-31, 2024

6th Euro Cardiology Congress

Vienna, Austria
May 30-31, 2024

39th World Congress on Heart Diseases

Vienna, Austria
June 20-21, 2024

5th European Summit on Cardiology Research

Dublin, Ireland
July 16-17, 2024

13th World Heart Congress

Paris, France
August 01-02, 2024

38th World Congress on Heart Diseases

Montreal, Canada
September 16-17, 2024

3rd Global Summit on Cardiology and Cardiac Surgery

Paris, France
October 24-25, 2024

11th International Conference on Interventional Cardiology

Zurich, Switzerland
October 30-31, 2024

7th Global Cardiovascular Research and Clinical Cardiology

Vancouver, Canada

Incidence and Prognosis of Refractory Hypertension in Patients Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in